Management of precancerous conditions and lesions in the stomach (MAPS): guideline from the European Society of Gastrointestinal Endoscopy (ESGE), European Helicobacter Study Group (EHSG), European Society of Pathology (ESP), and the Sociedade Portug (Q57698678)

From Wikidata

Jump to navigation Jump to search

scientific article published on 22 December 2011

Language	Label	Description	Also known as
English	Management of precancerous conditions and lesions in the stomach (MAPS): guideline from the European Society of Gastrointestinal Endoscopy (ESGE), European Helicobacter Study Group (EHSG), European Society of Pathology (ESP), and the Sociedade Portug	scientific article published on 22 December 2011

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22190006%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Management of precancerous conditions and lesions in the stomach (MAPS): guideline from the European Society of Gastrointestinal Endoscopy (ESGE), European Helicobacter Study Group (EHSG), European Society of Pathology (ESP), and the Sociedade Portuguesa de Endoscopia Digestiva (SPED) (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22190006%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

0 references

gastrointestinal endoscopy

1 reference

based on heuristic

inferred from title

Mário Dinis-Ribeiro

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22190006%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Ricardo Marcos-Pinto

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22190006%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Matilde Monteiro-Soares

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22190006%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22190006%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Pedro Pimentel-Nunes

8

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22190006%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Jean-Marc Dumonceau

11

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22190006%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Fatima Carneiro

23

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22190006%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

European Society of Gastrointestinal Endoscopy

26

object named as

European Society of Gastrointestinal Endoscopy

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22190006%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

author name string

M Areia

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22190006%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

A C de Vries

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22190006%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

A O'Connor

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22190006%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

R Correia

9

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22190006%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

A Ensari

10

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22190006%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

J C Machado

12

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22190006%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

G Macedo

13

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22190006%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

P Malfertheiner

14

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22190006%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

T Matysiak-Budnik

15

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22190006%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

F Megraud

16

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22190006%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

K Miki

17

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22190006%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

C O'Morain

18

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22190006%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

R M Peek

19

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22190006%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

T Ponchon

20

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22190006%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

A Ristimaki

21

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22190006%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

B Rembacken

22

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22190006%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

E J Kuipers

24

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22190006%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

MAPS Participants

25

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22190006%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

European Helicobacter Study Group

27

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22190006%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

European Society of Pathology

28

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22190006%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Sociedade Portuguesa de Endoscopia Digestiva

29

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22190006%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

publication date

22 December 2011

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22190006%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Virchows Archiv

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22190006%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

460

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22190006%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

19-46

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22190006%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22190006%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

https://scigraph.springernature.com/pub.10.1007/s00428-011-1177-8

0 references

Development and validation of an international appraisal instrument for assessing the quality of clinical practice guidelines: the AGREE project

1 reference

https://api.crossref.org/works/10.1007%2FS00428-011-1177-8

21 January 2018

Grading quality of evidence and strength of recommendations

1 reference

https://api.crossref.org/works/10.1007%2FS00428-011-1177-8

21 January 2018

GRADE: an emerging consensus on rating quality of evidence and strength of recommendations

1 reference

https://api.crossref.org/works/10.1007%2FS00428-011-1177-8

21 January 2018

A new system for grading recommendations in evidence based guidelines

1 reference

https://api.crossref.org/works/10.1007%2FS00428-011-1177-8

21 January 2018

Gastric atrophy, metaplasia, and dysplasia: a clinical perspective

1 reference

https://api.crossref.org/works/10.1007%2FS00428-011-1177-8

21 January 2018

Current thoughts on the histopathogenesis of gastric cancer.

1 reference

https://api.crossref.org/works/10.1007%2FS00428-011-1177-8

21 January 2018

Long-term observation of subjects with normal mucosa and with superficial gastritis: results of 23--27 years' follow-up examinations

1 reference

https://api.crossref.org/works/10.1007%2FS00428-011-1177-8

21 January 2018

Five year follow-up study of gastritis

1 reference

https://api.crossref.org/works/10.1007%2FS00428-011-1177-8

21 January 2018

The Sydney System: a new classification of gastritis. Introduction

1 reference

https://api.crossref.org/works/10.1007%2FS00428-011-1177-8

21 January 2018

Histological diagnosis of precancerous lesions of the stomach: a reliability study.

1 reference

https://api.crossref.org/works/10.1007%2FS00428-011-1177-8

21 January 2018

Incomplete sulphomucin-secreting intestinal metaplasia for gastric cancer. Preliminary data from a prospective study from three centres

1 reference

https://api.crossref.org/works/10.1007%2FS00428-011-1177-8

21 January 2018

Expression of intestinal mucin antigens in the gastric epithelium and its relationship with malignancy.

1 reference

https://api.crossref.org/works/10.1007%2FS00428-011-1177-8

21 January 2018

Variants of intestinal metaplasia in the evolution of chronic atrophic gastritis and gastric ulcer. A follow up study

1 reference

https://api.crossref.org/works/10.1007%2FS00428-011-1177-8

21 January 2018

Biology of intestinal metaplasia in 2008: more than a simple phenotypic alteration.

1 reference

https://api.crossref.org/works/10.1007%2FS00428-011-1177-8

21 January 2018

Gastric precancerous lesions: heading for an international consensus

1 reference

https://api.crossref.org/works/10.1007%2FS00428-011-1177-8

21 January 2018

The pathology of epithelial pre-malignancy of the gastrointestinal tract

1 reference

https://api.crossref.org/works/10.1007%2FS00428-011-1177-8

21 January 2018

Long-term follow-up study of gastric intraepithelial neoplasias: progression from low-grade dysplasia to invasive carcinoma.

1 reference

https://api.crossref.org/works/10.1007%2FS00428-011-1177-8

21 January 2018

Gastric cancer risk in patients with premalignant gastric lesions: a nationwide cohort study in the Netherlands

1 reference

https://api.crossref.org/works/10.1007%2FS00428-011-1177-8

21 January 2018

A follow up model for patients with atrophic chronic gastritis and intestinal metaplasia

1 reference

https://api.crossref.org/works/10.1007%2FS00428-011-1177-8

21 January 2018

The long term results of endoscopic surveillance of premalignant gastric lesions

1 reference

https://api.crossref.org/works/10.1007%2FS00428-011-1177-8

21 January 2018

Risk of gastric carcinoma in patients with mucosal dysplasia associated with atrophic gastritis: a follow up study

1 reference

https://api.crossref.org/works/10.1007%2FS00428-011-1177-8

21 January 2018

Early and advanced gastric cancer in the follow-up of moderate and severe gastric dysplasia patients. A prospective study. I.G.G.E.D.--Interdisciplinary Group on Gastric Epithelial Dysplasia

1 reference

https://api.crossref.org/works/10.1007%2FS00428-011-1177-8

21 January 2018

An evaluation of gastric dysplasia in the years 1986 and 1987.

1 reference

https://api.crossref.org/works/10.1007%2FS00428-011-1177-8

21 January 2018

High grade dysplasia of the gastric mucosa: a marker for gastric carcinoma

1 reference

https://api.crossref.org/works/10.1007%2FS00428-011-1177-8

21 January 2018

Risk of cancer in patients with gastric dysplasia. Follow-up study of 67 patients.

1 reference

https://api.crossref.org/works/10.1007%2FS00428-011-1177-8

21 January 2018

Dysplasia in inflammatory bowel disease: standardized classification with provisional clinical applications.

1 reference

https://api.crossref.org/works/10.1007%2FS00428-011-1177-8

21 January 2018

Evaluation of gastric biopsies for neoplasia: differences between Japanese and Western pathologists.

1 reference

https://api.crossref.org/works/10.1007%2FS00428-011-1177-8

21 January 2018

Gastroscopy is incomplete without biopsy: clinical relevance of distinguishing gastropathy from gastritis

1 reference

https://api.crossref.org/works/10.1007%2FS00428-011-1177-8

21 January 2018

The correlation of endoscopic and histological diagnosis of gastric atrophy.

1 reference

https://api.crossref.org/works/10.1007%2FS00428-011-1177-8

21 January 2018

Mucosal patterns of Helicobacter pylori-related gastritis without atrophy in the gastric corpus using standard endoscopy

1 reference

https://api.crossref.org/works/10.1007%2FS00428-011-1177-8

21 January 2018

Interobserver agreement and predictive value of endoscopic findings for H. pylori and gastritis in normal volunteers.

1 reference

https://api.crossref.org/works/10.1007%2FS00428-011-1177-8

21 January 2018

Magnification chromoendoscopy for the diagnosis of gastric intestinal metaplasia and dysplasia.

1 reference

https://api.crossref.org/works/10.1007%2FS00428-011-1177-8

21 January 2018

External validation of a classification for methylene blue magnification chromoendoscopy in premalignant gastric lesions.

1 reference

https://api.crossref.org/works/10.1007%2FS00428-011-1177-8

21 January 2018

Chromoendoscopy with hematoxylin in the classification of gastric lesions

1 reference

https://api.crossref.org/works/10.1007%2FS00428-011-1177-8

21 January 2018

High-resolution magnification endoscopy can reliably identify normal gastric mucosa, Helicobacter pylori-associated gastritis, and gastric atrophy

1 reference

https://api.crossref.org/works/10.1007%2FS00428-011-1177-8

21 January 2018

Comparison of high resolution magnifying endoscopy and standard videoendoscopy for the diagnosis of Helicobacter pylori gastritis in routine clinical practice: a prospective study.

1 reference

https://api.crossref.org/works/10.1007%2FS00428-011-1177-8

21 January 2018

Gastric mucosal pattern by using magnifying narrow-band imaging endoscopy clearly distinguishes histological and serological severity of chronic gastritis.

1 reference

https://api.crossref.org/works/10.1007%2FS00428-011-1177-8

21 January 2018

Correlation between narrow band imaging and nonneoplastic gastric pathology: a pilot feasibility trial

1 reference

https://api.crossref.org/works/10.1007%2FS00428-011-1177-8

21 January 2018

Magnifying endoscopy with narrow-band imaging achieves superior accuracy in the differential diagnosis of superficial gastric lesions identified with white-light endoscopy: a prospective study.

1 reference

https://api.crossref.org/works/10.1007%2FS00428-011-1177-8

21 January 2018

Ease of early gastric cancer demarcation recognition: a comparison of four magnifying endoscopy methods

1 reference

https://api.crossref.org/works/10.1007%2FS00428-011-1177-8

21 January 2018

A new method of diagnosing gastric intestinal metaplasia: narrow-band imaging with magnifying endoscopy.

1 reference

https://api.crossref.org/works/10.1007%2FS00428-011-1177-8

21 January 2018

Narrow band imaging for the detection of gastric intestinal metaplasia and dysplasia during surveillance endoscopy

1 reference

https://api.crossref.org/works/10.1007%2FS00428-011-1177-8

21 January 2018

Evaluation of gastric mucosal biopsy site and number for identification of Helicobacter pylori or intestinal metaplasia: role of the Sydney System

1 reference

https://api.crossref.org/works/10.1007%2FS00428-011-1177-8

21 January 2018

Staging and grading of chronic gastritis

1 reference

https://api.crossref.org/works/10.1007%2FS00428-011-1177-8

21 January 2018

Atrophic gastritis: pathology and endoscopy in the reversibility assessment.

1 reference

https://api.crossref.org/works/10.1007%2FS00428-011-1177-8

21 January 2018

Atrophic gastritis in young children and adolescents

1 reference

https://api.crossref.org/works/10.1007%2FS00428-011-1177-8

21 January 2018

Patterns of gastric atrophy in intestinal type gastric carcinoma

1 reference

https://api.crossref.org/works/10.1007%2FS00428-011-1177-8

21 January 2018

Gastric intestinal metaplasia: subtypes and natural history

1 reference

https://api.crossref.org/works/10.1007%2FS00428-011-1177-8

21 January 2018

OLGA staging for gastritis: a tutorial

1 reference

https://api.crossref.org/works/10.1007%2FS00428-011-1177-8

21 January 2018

Staging gastritis: an international proposal.

1 reference

https://api.crossref.org/works/10.1007%2FS00428-011-1177-8

21 January 2018

Gastritis staging in clinical practice: the OLGA staging system

1 reference

https://api.crossref.org/works/10.1007%2FS00428-011-1177-8

21 January 2018

Assessment of atrophic gastritis using the OLGA system

1 reference

https://api.crossref.org/works/10.1007%2FS00428-011-1177-8

21 January 2018

Interobserver variability in application of the revised Sydney classification for gastritis

1 reference

https://api.crossref.org/works/10.1007%2FS00428-011-1177-8

21 January 2018

Meta-analysis on the validity of pepsinogen test for gastric carcinoma, dysplasia or chronic atrophic gastritis screening

1 reference

https://api.crossref.org/works/10.1007%2FS00428-011-1177-8

21 January 2018

Noninvasive versus histologic detection of gastric atrophy in a Hispanic population in North America

1 reference

https://api.crossref.org/works/10.1007%2FS00428-011-1177-8

21 January 2018

Serum pepsinogen I, pepsinogen II, and gastrin 17 in relatives of gastric cancer patients: comparative study with type and severity of gastritis.

1 reference

https://api.crossref.org/works/10.1007%2FS00428-011-1177-8

21 January 2018

Serum biomarker tests are useful in delineating between patients with gastric atrophy and normal, healthy stomach

1 reference

https://api.crossref.org/works/10.1007%2FS00428-011-1177-8

21 January 2018

Clinical meaning of pepsinogen test and Helicobacter pylori serology in the health check-up population in Korea.

1 reference

https://api.crossref.org/works/10.1007%2FS00428-011-1177-8

21 January 2018

Helicobacter pylori gastritis and serum pepsinogen levels in a healthy population: development of a biomarker strategy for gastric atrophy in high risk groups

1 reference

https://api.crossref.org/works/10.1007%2FS00428-011-1177-8

21 January 2018

The validity of a biomarker method for indirect detection of gastric mucosal atrophy versus standard histopathology.

1 reference

https://api.crossref.org/works/10.1007%2FS00428-011-1177-8

21 January 2018

Invasive and non-invasive diagnosis of Helicobacter pylori-associated atrophic gastritis: a comparative study

1 reference

https://api.crossref.org/works/10.1007%2FS00428-011-1177-8

21 January 2018

Serological markers for gastric atrophy in asymptomatic patients infected with Helicobacter pylori.

1 reference

https://api.crossref.org/works/10.1007%2FS00428-011-1177-8

21 January 2018

Non-invasive diagnosis of gastric mucosal atrophy in an asymptomatic population with high prevalence of gastric cancer

1 reference

https://api.crossref.org/works/10.1007%2FS00428-011-1177-8

21 January 2018

Association of serum pepsinogen with atrophic body gastritis in Costa Rica

1 reference

https://api.crossref.org/works/10.1007%2FS00428-011-1177-8

21 January 2018

Serum biomarkers provide an accurate method for diagnosis of atrophic gastritis in a general population: The Kalixanda study.

1 reference

https://api.crossref.org/works/10.1007%2FS00428-011-1177-8

21 January 2018

Serum pepsinogen levels and their influencing factors: a population-based study in 6990 Chinese from North China

1 reference

https://api.crossref.org/works/10.1007%2FS00428-011-1177-8

21 January 2018

Diagnosis of atrophic body gastritis in Chinese patients by measuring serum pepsinogen

1 reference

https://api.crossref.org/works/10.1007%2FS00428-011-1177-8

21 January 2018

Non-endoscopic diagnosis of atrophic gastritis with a blood test. Correlation between gastric histology and serum levels of gastrin-17 and pepsinogen I: a multicentre study

1 reference

https://api.crossref.org/works/10.1007%2FS00428-011-1177-8

21 January 2018

Screening of atrophic gastritis and gastric cancer by serum pepsinogen, gastrin-17 and Helicobacter pylori immunoglobulin G antibodies

1 reference

https://api.crossref.org/works/10.1007%2FS00428-011-1177-8

21 January 2018

Serum pepsinogen levels, Helicobacter pylori CagA Status, and cytokine gene polymorphisms associated with gastric premalignant lesions in Costa Rica

1 reference

https://api.crossref.org/works/10.1007%2FS00428-011-1177-8

21 January 2018

Validity of serum pepsinogen I/II ratio for the diagnosis of gastric epithelial dysplasia and intestinal metaplasia during the follow-up of patients at risk for intestinal-type gastric adenocarcinoma

1 reference

https://api.crossref.org/works/10.1007%2FS00428-011-1177-8

21 January 2018

Serum pepsinogens as a predicator of the topography of intestinal metaplasia in patients with atrophic gastritis.

1 reference

https://api.crossref.org/works/10.1007%2FS00428-011-1177-8

21 January 2018

The use of clinical, histologic, and serologic parameters to predict the intragastric extent of intestinal metaplasia: a recommendation for routine practice

1 reference

https://api.crossref.org/works/10.1007%2FS00428-011-1177-8

21 January 2018

Predicting the development of gastric cancer from combining Helicobacter pylori antibodies and serum pepsinogen status: a prospective endoscopic cohort study

1 reference

https://api.crossref.org/works/10.1007%2FS00428-011-1177-8

21 January 2018

High-risk population for gastric cancer development based on serum pepsinogen status and lifestyle factors

1 reference

https://api.crossref.org/works/10.1007%2FS00428-011-1177-8

21 January 2018

Cancer high-risk subjects identified by serum pepsinogen tests: outcomes after 10-year follow-up in asymptomatic middle-aged males

1 reference

https://api.crossref.org/works/10.1007%2FS00428-011-1177-8

21 January 2018

Risk of gastric cancer in asymptomatic, middle-aged Japanese subjects based on serum pepsinogen and Helicobacter pylori antibody levels

1 reference

https://api.crossref.org/works/10.1007%2FS00428-011-1177-8

21 January 2018

The serum pepsinogen test as a predictor of gastric cancer: the Hisayama study

1 reference

https://api.crossref.org/works/10.1007%2FS00428-011-1177-8

21 January 2018

Feasibility and cost-effectiveness of using magnification chromoendoscopy and pepsinogen serum levels for the follow-up of patients with atrophic chronic gastritis and intestinal metaplasia.

1 reference

https://api.crossref.org/works/10.1007%2FS00428-011-1177-8

21 January 2018

Circulating anti-Helicobacter pylori immunoglobulin A antibodies and low serum pepsinogen I level are associated with increased risk of gastric cancer.

1 reference

https://api.crossref.org/works/10.1007%2FS00428-011-1177-8

21 January 2018

Helicobacter pylori infection, serum pepsinogen level and gastric cancer: a case-control study in Japan

1 reference

https://api.crossref.org/works/10.1007%2FS00428-011-1177-8

21 January 2018

Helicobacter pylori infection and low serum pepsinogen I level as risk factors for gastric carcinoma

1 reference

https://api.crossref.org/works/10.1007%2FS00428-011-1177-8

21 January 2018

Predictive power of serum pepsinogen tests for the development of gastric cancer in comparison to the histologic risk index.

1 reference

https://api.crossref.org/works/10.1007%2FS00428-011-1177-8

21 January 2018

The significance of low serum pepsinogen levels to detect stomach cancer associated with extensive chronic gastritis in Japanese subjects.

1 reference

https://api.crossref.org/works/10.1007%2FS00428-011-1177-8

21 January 2018

Serum pepsinogens and risk of gastric and oesophageal cancers in the General Population Nutrition Intervention Trial cohort

1 reference

https://api.crossref.org/works/10.1007%2FS00428-011-1177-8

21 January 2018

Histologic and serum risk markers for noncardia early gastric cancer

1 reference

https://api.crossref.org/works/10.1007%2FS00428-011-1177-8

21 January 2018

Serum pepsinogen levels in gastric cancer patients and their relationship with Helicobacter pylori infection: a prospective study.

1 reference

https://api.crossref.org/works/10.1007%2FS00428-011-1177-8

21 January 2018

Anti-parietal cell antibody and serum pepsinogen assessment in screening for gastric carcinoma.

1 reference

https://api.crossref.org/works/10.1007%2FS00428-011-1177-8

21 January 2018

Reduction in gastric cancer mortality by screening based on serum pepsinogen concentration: a case-control study

1 reference

https://api.crossref.org/works/10.1007%2FS00428-011-1177-8

21 January 2018

Sensitivity and specificity of mass screening for gastric cancer using the measurment of serum pepsinogens

1 reference

https://api.crossref.org/works/10.1007%2FS00428-011-1177-8

21 January 2018

Accuracy of screening for gastric cancer using serum pepsinogen concentrations

1 reference

https://api.crossref.org/works/10.1007%2FS00428-011-1177-8

21 January 2018

Clinical application of serum pepsinogen I and II levels for mass screening to detect gastric cancer.

1 reference

https://api.crossref.org/works/10.1007%2FS00428-011-1177-8

21 January 2018

Usefulness of gastric cancer screening using the serum pepsinogen test method

1 reference

https://api.crossref.org/works/10.1007%2FS00428-011-1177-8

21 January 2018

Incidence of gastric cancer and breast cancer in CDH1 (E-cadherin) mutation carriers from hereditary diffuse gastric cancer families

1 reference

https://api.crossref.org/works/10.1007%2FS00428-011-1177-8

21 January 2018

Hereditary diffuse gastric cancer: updated consensus guidelines for clinical management and directions for future research

1 reference

https://api.crossref.org/works/10.1007%2FS00428-011-1177-8

21 January 2018

The risk of extra-colonic, extra-endometrial cancer in the Lynch syndrome.

1 reference

https://api.crossref.org/works/10.1007%2FS00428-011-1177-8

21 January 2018

Risk and epidemiological time trends of gastric cancer in Lynch syndrome carriers in the Netherlands.

1 reference

https://api.crossref.org/works/10.1007%2FS00428-011-1177-8

21 January 2018

Very high risk of cancer in familial Peutz-Jeghers syndrome

1 reference

https://api.crossref.org/works/10.1007%2FS00428-011-1177-8

21 January 2018

High cancer risk and increased mortality in patients with Peutz-Jeghers syndrome

1 reference

https://api.crossref.org/works/10.1007%2FS00428-011-1177-8

21 January 2018

Family history and the risk of gastric cancer

1 reference

https://api.crossref.org/works/10.1007%2FS00428-011-1177-8

21 January 2018

Family history of cancer and risk of esophageal and gastric cancers in the United States

1 reference

https://api.crossref.org/works/10.1007%2FS00428-011-1177-8

21 January 2018

Associations between cigarette smoking and the risk of four leading cancers in Miyagi Prefecture, Japan: A multi‐site case‐control study

1 reference

https://api.crossref.org/works/10.1007%2FS00428-011-1177-8

21 January 2018

Family history of cancer and stomach cancer risk

1 reference

https://api.crossref.org/works/10.1007%2FS00428-011-1177-8

21 January 2018

Family history of gastric cancer: a correlation between epidemiologic findings and clinical data.

1 reference

https://api.crossref.org/works/10.1007%2FS00428-011-1177-8

21 January 2018

Helicobacter pylori infection and gastric histology in first-degree relatives of gastric cancer patients: a meta-analysis

1 reference

https://api.crossref.org/works/10.1007%2FS00428-011-1177-8

21 January 2018

Helicobacter pylori and interleukin 1 genotyping: an opportunity to identify high-risk individuals for gastric carcinoma

1 reference

https://api.crossref.org/works/10.1007%2FS00428-011-1177-8

21 January 2018

Host-bacterial interactions in Helicobacter pylori infection

1 reference

https://api.crossref.org/works/10.1007%2FS00428-011-1177-8

21 January 2018

Meta-analysis of the relationship between cagA seropositivity and gastric cancer.

1 reference

https://api.crossref.org/works/10.1007%2FS00428-011-1177-8

21 January 2018

Clinical relevance of Helicobacter pylori cagA and vacA gene polymorphisms.

1 reference

https://api.crossref.org/works/10.1007%2FS00428-011-1177-8

21 January 2018

Interleukin-1 polymorphisms associated with increased risk of gastric cancer

1 reference

https://api.crossref.org/works/10.1007%2FS00428-011-1177-8

21 January 2018

Polymorphisms in inflammatory response genes and their association with gastric cancer: A HuGE systematic review and meta-analyses

1 reference

https://api.crossref.org/works/10.1007%2FS00428-011-1177-8

21 January 2018

Interleukin-1beta and interleukin-1 receptor antagonist gene polymorphisms and gastric cancer: a meta-analysis.

1 reference

https://api.crossref.org/works/10.1007%2FS00428-011-1177-8

21 January 2018

Interleukin-1B and interleukin-1 RN polymorphisms and gastric carcinoma risk: a meta-analysis

1 reference

https://api.crossref.org/works/10.1007%2FS00428-011-1177-8

21 January 2018

Interleukin-1B polymorphisms and gastric cancer risk--a meta-analysis

1 reference

https://api.crossref.org/works/10.1007%2FS00428-011-1177-8

21 January 2018

The Vienna classification of gastrointestinal epithelial neoplasia

1 reference

https://api.crossref.org/works/10.1007%2FS00428-011-1177-8

21 January 2018

Gastric epithelial dysplasia. How clinicopathologic background relates to management.

1 reference

https://api.crossref.org/works/10.1007%2FS00428-011-1177-8

21 January 2018

The long term outcome of gastric non-invasive neoplasia

1 reference

https://api.crossref.org/works/10.1007%2FS00428-011-1177-8

21 January 2018

Risk of malignant progression in patients with Barrett's oesophagus: a Dutch nationwide cohort study.

1 reference

https://api.crossref.org/works/10.1007%2FS00428-011-1177-8

21 January 2018

Review article: the incidence and prevalence of colorectal cancer in inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1007%2FS00428-011-1177-8

21 January 2018

Gastric adenomas: intestinal-type and gastric-type adenomas differ in the risk of adenocarcinoma and presence of background mucosal pathology.

1 reference

https://api.crossref.org/works/10.1007%2FS00428-011-1177-8

21 January 2018

The British Society of Gastroenterology early gastric cancer/dysplasia survey: an interim report

1 reference

https://api.crossref.org/works/10.1007%2FS00428-011-1177-8

21 January 2018

Histologic diagnosis based on forceps biopsy is not adequate for determining endoscopic treatment of gastric adenomatous lesions.

1 reference

https://api.crossref.org/works/10.1007%2FS00428-011-1177-8

21 January 2018

Carcinoma arising from areas of intestinal metaplasia in the gastric mucosa

1 reference

https://api.crossref.org/works/10.1007%2FS00428-011-1177-8

21 January 2018

Long-term follow-up in atrophic body gastritis patients: atrophy and intestinal metaplasia are persistent lesions irrespective of Helicobacter pylori infection.

1 reference

https://api.crossref.org/works/10.1007%2FS00428-011-1177-8

21 January 2018

The gastric transitional zones: neglected links between gastroduodenal pathology and helicobacter ecology

1 reference

https://api.crossref.org/works/10.1007%2FS00428-011-1177-8

21 January 2018

Detection of an increased incidence of early gastric cancer in patients with intestinal metaplasia type III who are closely followed up

1 reference

https://api.crossref.org/works/10.1007%2FS00428-011-1177-8

21 January 2018

Limited value of type III intestinal metaplasia in predicting risk of gastric carcinoma

1 reference

https://api.crossref.org/works/10.1007%2FS00428-011-1177-8

21 January 2018

Effect of early eradication on Helicobacter pylori-related gastric carcinogenesis in Mongolian gerbils.

1 reference

https://api.crossref.org/works/10.1007%2FS00428-011-1177-8

21 January 2018

Eradication of Helicobacter pylori decreases mucosal alterations linked to gastric carcinogenesis in Mongolian gerbils

1 reference

https://api.crossref.org/works/10.1007%2FS00428-011-1177-8

21 January 2018

Helicobacter pylori eradication improves gastric histology and decreases serum gastrin, pepsinogen I and pepsinogen II levels in patients with duodenal ulcer.

1 reference

https://api.crossref.org/works/10.1007%2FS00428-011-1177-8

21 January 2018

The long-term impact of Helicobacter pylori eradication on gastric histology: a systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1007%2FS00428-011-1177-8

21 January 2018

Review article: Helicobacter pylori eradication for the prevention of gastric cancer

1 reference

https://api.crossref.org/works/10.1007%2FS00428-011-1177-8

21 January 2018

Gastric atrophy and intestinal metaplasia before and after Helicobacter pylori eradication: a meta-analysis

1 reference

https://api.crossref.org/works/10.1007%2FS00428-011-1177-8

21 January 2018

Cure of Helicobacter pylori infection in atrophic body gastritis patients does not improve mucosal atrophy but reduces hypergastrinemia and its related effects on body ECL-cell hyperplasia

1 reference

https://api.crossref.org/works/10.1007%2FS00428-011-1177-8

21 January 2018

Long term follow up of patients treated for Helicobacter pylori infection.

1 reference

https://api.crossref.org/works/10.1007%2FS00428-011-1177-8

21 January 2018

Helicobacter pylori eradication to prevent gastric cancer in a high-risk region of China: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1007%2FS00428-011-1177-8

21 January 2018

Systematic review: Helicobacter pylori eradication for the prevention of gastric cancer

1 reference

https://api.crossref.org/works/10.1007%2FS00428-011-1177-8

21 January 2018

Meta-analysis: can Helicobacter pylori eradication treatment reduce the risk for gastric cancer?

1 reference

https://api.crossref.org/works/10.1007%2FS00428-011-1177-8

21 January 2018

Helicobacter pylori infection and development of gastric cancer in Korea: long-term follow-up

1 reference

https://api.crossref.org/works/10.1007%2FS00428-011-1177-8

21 January 2018

Factors predicting progression of gastric intestinal metaplasia: results of a randomised trial on Helicobacter pylori eradication

1 reference

https://api.crossref.org/works/10.1007%2FS00428-011-1177-8

21 January 2018

Randomized double-blind factorial trial of three treatments to reduce the prevalence of precancerous gastric lesions

1 reference

https://api.crossref.org/works/10.1007%2FS00428-011-1177-8

21 January 2018

The effect of eradicating helicobacter pylori on the development of gastric cancer in patients with peptic ulcer disease

1 reference

https://api.crossref.org/works/10.1007%2FS00428-011-1177-8

21 January 2018

Effect of eradication of Helicobacter pylori on incidence of metachronous gastric carcinoma after endoscopic resection of early gastric cancer: an open-label, randomised controlled trial

1 reference

https://api.crossref.org/works/10.1007%2FS00428-011-1177-8

21 January 2018

H. pylori eradication prevents the progression of gastric intestinal metaplasia in reflux esophagitis patients using long-term esomeprazole

1 reference

https://api.crossref.org/works/10.1007%2FS00428-011-1177-8

21 January 2018

Current concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus Report

1 reference

https://api.crossref.org/works/10.1007%2FS00428-011-1177-8

21 January 2018

Report of the 1997 Asia Pacific Consensus Conference on the management of Helicobacter pylori infection

1 reference

https://api.crossref.org/works/10.1007%2FS00428-011-1177-8

21 January 2018

Current concepts in the management of Helicobacter pylori infection--the Maastricht 2-2000 Consensus Report

1 reference

https://api.crossref.org/works/10.1007%2FS00428-011-1177-8

21 January 2018

Second Asia-Pacific Consensus Guidelines for Helicobacter pylori infection

1 reference

https://api.crossref.org/works/10.1007%2FS00428-011-1177-8

21 January 2018

Cost-effectiveness of eradication of Helicobacter pylori in gastric cancer survivors after endoscopic resection of early gastric cancer

1 reference

https://api.crossref.org/works/10.1007%2FS00428-011-1177-8

21 January 2018

Non-steroidal anti-inflammatory drug use and the risk of gastric cancer: a systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1007%2FS00428-011-1177-8

21 January 2018

Meta-analysis on the relationship between nonsteroidal anti-inflammatory drug use and gastric cancer.

1 reference

https://api.crossref.org/works/10.1007%2FS00428-011-1177-8

21 January 2018

Anti-Helicobacter pylori therapy followed by celecoxib on progression of gastric precancerous lesions

1 reference

https://api.crossref.org/works/10.1007%2FS00428-011-1177-8

21 January 2018

Short-term celecoxib to regress long-term persistent gastric intestinal metaplasia after Helicobacter pylori eradication

1 reference

https://api.crossref.org/works/10.1007%2FS00428-011-1177-8

21 January 2018

Effective reduction of gastric cancer risk with regular use of nonsteroidal anti-inflammatory drugs in Helicobacter pylori-infected patients

1 reference

https://api.crossref.org/works/10.1007%2FS00428-011-1177-8

21 January 2018

The cost-effectiveness of population Helicobacter pylori screening and treatment: a Markov model using economic data from a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1007%2FS00428-011-1177-8

21 January 2018

Modelling cost-effectiveness of Helicobacter pylori screening to prevent gastric cancer: a mandate for clinical trials

1 reference

https://api.crossref.org/works/10.1007%2FS00428-011-1177-8

21 January 2018

Cost-Effectiveness of Population Screening for Helicobacter Pylori in Preventing Gastric Cancer and Peptic Ulcer Disease, Using Simulation

1 reference

https://api.crossref.org/works/10.1007%2FS00428-011-1177-8

21 January 2018

Cost-benefit analysis of Helicobacter pylori screening.

1 reference

https://api.crossref.org/works/10.1007%2FS00428-011-1177-8

21 January 2018

Exploring the cost-effectiveness of Helicobacter pylori screening to prevent gastric cancer in China in anticipation of clinical trial results

1 reference

https://api.crossref.org/works/10.1007%2FS00428-011-1177-8

21 January 2018

Cost-effectiveness analysis between primary and secondary preventive strategies for gastric cancer.

1 reference

https://api.crossref.org/works/10.1007%2FS00428-011-1177-8

21 January 2018

Comparing upper gastrointestinal X-ray and endoscopy for gastric cancer diagnosis in Korea

1 reference

https://api.crossref.org/works/10.1007%2FS00428-011-1177-8

21 January 2018

Cost-effectiveness analysis of Helicobacter pylori screening in prevention of gastric cancer in Chinese

1 reference

https://api.crossref.org/works/10.1007%2FS00428-011-1177-8

21 January 2018

Cost effectiveness analysis of population-based serology screening and (13)C-Urea breath test for Helicobacter pylori to prevent gastric cancer: a markov model

1 reference

https://api.crossref.org/works/10.1007%2FS00428-011-1177-8

21 January 2018

Cost-effectiveness of treatment and endoscopic surveillance of precancerous lesions to prevent gastric cancer

1 reference

https://api.crossref.org/works/10.1007%2FS00428-011-1177-8

21 January 2018

Cost-effectiveness of endoscopic surveillance for gastric intestinal metaplasia

1 reference

https://api.crossref.org/works/10.1007%2FS00428-011-1177-8

21 January 2018

Gastric Cancer Susceptibility Is Not Linked to Pro-and Anti-Inflammatory Cytokine Gene Polymorphisms in Whites: A Nationwide Multicenter Study in Spain

1 reference

https://api.crossref.org/works/10.1007%2FS00428-011-1177-8

21 January 2018

Chemoprevention of Precancerous Gastric Lesions With Antioxidant Vitamin Supplementation: A Randomized Trial in a High-Risk Population

1 reference

https://api.crossref.org/works/10.1007%2FS00428-011-1177-8

21 January 2018

A proinflammatory genetic profile increases the risk for chronic atrophic gastritis and gastric carcinoma

1 reference

https://api.crossref.org/works/10.1007%2FS00428-011-1177-8

21 January 2018

Gastric intestinal metaplasia type III cases are classified as low-grade dysplasia on the basis of morphometry

1 reference

https://pubmed.ncbi.nlm.nih.gov/22190006

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Serum pepsinogen I as a predictor of stomach cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/22190006

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The staging of gastritis with the OLGA system by using intestinal metaplasia as an accurate alternative for atrophic gastritis

1 reference

https://pubmed.ncbi.nlm.nih.gov/22190006

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Gastric dysplasia. A histological follow-up study

1 reference

https://pubmed.ncbi.nlm.nih.gov/22190006

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Chronic celecoxib users more often show regression of gastric intestinal metaplasia after Helicobacter pylori eradication

1 reference

https://pubmed.ncbi.nlm.nih.gov/22190006

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Natural history of untreated colonic polyps.

1 reference

https://pubmed.ncbi.nlm.nih.gov/22190006

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Family history and the risk of stomach and colorectal cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/22190006

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical implications of recent developments in gastric cancer pathology and epidemiology

1 reference

https://pubmed.ncbi.nlm.nih.gov/22190006

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The clinical significance of gastric epithelial dysplasia

1 reference

https://pubmed.ncbi.nlm.nih.gov/22190006

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Non-endoscopic diagnosis of multifocal atrophic gastritis; efficacy of serum gastrin-17, pepsinogens and Helicobacter pylori antibodies.

1 reference

https://pubmed.ncbi.nlm.nih.gov/22190006

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Gastritis OLGA-staging & gastric cancer risk: a twelve year clinico-pathological follow-up study

1 reference

https://pubmed.ncbi.nlm.nih.gov/22190006

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Long-term follow-up study of gastric adenoma/dysplasia

1 reference

https://pubmed.ncbi.nlm.nih.gov/22190006

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Usefulness of serum pepsinogens in Helicobacter pylori chronic gastritis: relationship with inflammation, activity, and density of the bacterium

1 reference

https://pubmed.ncbi.nlm.nih.gov/22190006

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Diagnostic value of endoscopic signs of gastritis: with special emphasis to nodular antritis

1 reference

https://pubmed.ncbi.nlm.nih.gov/22190006

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Conventional narrow-band imaging has good correlation with histopathological severity of Helicobacter pylori gastritis

1 reference

https://pubmed.ncbi.nlm.nih.gov/22190006

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Review article: Gastric atrophy and atrophic gastritis--nebulous concepts in search of a definition

1 reference

https://pubmed.ncbi.nlm.nih.gov/22190006

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of Helicobacter pylori infection combined with CagA and pepsinogen status on gastric cancer development among Japanese men and women: a nested case-control study

1 reference

https://pubmed.ncbi.nlm.nih.gov/22190006

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Family history and risk of stomach cancer in Italy

1 reference

https://pubmed.ncbi.nlm.nih.gov/22190006

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Long-term results of gastric cancer screening using the serum pepsinogen test method among an asymptomatic middle-aged Japanese population

1 reference

https://pubmed.ncbi.nlm.nih.gov/22190006

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Helicobacter pylori, pepsinogen, and risk for gastric adenocarcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/22190006

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Correlation between endoscopic features of gastric antrum, histology and Helicobacter pylori infection in adults.

1 reference

https://pubmed.ncbi.nlm.nih.gov/22190006

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Serological parameters in assessment of degree of gastritis in healthy volunteers

1 reference

https://pubmed.ncbi.nlm.nih.gov/22190006

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The long-term risk of gastric cancer after the successful eradication of Helicobacter pylori

1 reference

https://pubmed.ncbi.nlm.nih.gov/22190006

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Preventive effects of etodolac, a selective cyclooxygenase-2 inhibitor, on cancer development in extensive metaplastic gastritis, a Helicobacter pylori-negative precancerous lesion

1 reference

https://pubmed.ncbi.nlm.nih.gov/22190006

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Dysplasia in gastric mucosa: prognostic significance

1 reference

https://pubmed.ncbi.nlm.nih.gov/22190006

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Familial clustering in subgroups of gastric cancer stratified by histology, age group and location

1 reference

https://pubmed.ncbi.nlm.nih.gov/22190006

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Gastric dysplasia and its management

1 reference

https://pubmed.ncbi.nlm.nih.gov/22190006

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The two histological main types of gastric carcinoma: diffuse and so called intestinal-type carcinoma: an attempt at a histo-clinical classification

1 reference

https://pubmed.ncbi.nlm.nih.gov/22190006

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Can we justify resecting all gastric epithelial dysplastic lesions?

1 reference

https://pubmed.ncbi.nlm.nih.gov/22190006

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Endoscopic features of Helicobacter pylori-related gastritis

1 reference

https://pubmed.ncbi.nlm.nih.gov/22190006

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of long-term rofecoxib on gastric intestinal metaplasia: results of a randomized controlled trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/22190006

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Atrophic chronic gastritis and intestinal metaplasia in gastric carcinoma. Comparison with a representative population sample

1 reference

https://pubmed.ncbi.nlm.nih.gov/22190006

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Endoscopic mucosal resection: an improved diagnostic procedure for early gastroesophageal epithelial neoplasms

1 reference

https://pubmed.ncbi.nlm.nih.gov/22190006

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Serum pepsinogen in screening for gastric cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/22190006

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Gastric dysplasia. A follow-up study.

1 reference

https://pubmed.ncbi.nlm.nih.gov/22190006

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Confirmation of successful therapy of Helicobacter pylori infection: number and site of biopsies or a rapid urease test

1 reference

https://pubmed.ncbi.nlm.nih.gov/22190006

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Risk factors for progression to gastric neoplastic lesions in patients with atrophic gastritis.

1 reference

https://pubmed.ncbi.nlm.nih.gov/22190006

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Classification and grading of gastritis. The updated Sydney System. International Workshop on the Histopathology of Gastritis, Houston 1994

1 reference

https://pubmed.ncbi.nlm.nih.gov/22190006

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Serum pepsinogen concentration as a marker of Helicobacter pyloriinfection and the histologic grade of gastritis; evaluation of gastric mucosa by serum pepsinogen levels

1 reference

https://pubmed.ncbi.nlm.nih.gov/22190006

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Gastric dysplasia: a ten-year follow-up study

1 reference

https://pubmed.ncbi.nlm.nih.gov/22190006

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The risk of upper gastrointestinal cancer in familial adenomatous polyposis

1 reference

https://pubmed.ncbi.nlm.nih.gov/22190006

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Endoscopic diagnosis of intestinal metaplasia

1 reference

https://pubmed.ncbi.nlm.nih.gov/22190006

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Gastric epithelial dysplasia in the natural history of gastric cancer: a multicenter prospective follow-up study. Interdisciplinary Group on Gastric Epithelial Dysplasia

1 reference

https://pubmed.ncbi.nlm.nih.gov/22190006

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Evolution of precancerous lesions in a rural Chinese population at high risk of gastric cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/22190006

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A human model of gastric carcinogenesis.

1 reference

https://pubmed.ncbi.nlm.nih.gov/22190006

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparison of the validity of three biomarkers for gastric cancer screening: carcinoembryonic antigen, pepsinogens, and high sensitive C-reactive protein

1 reference

https://pubmed.ncbi.nlm.nih.gov/22190006

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Molecular epidemiology of genetic susceptibility to gastric cancer: focus on single nucleotide polymorphisms in gastric carcinogenesis

1 reference

https://pubmed.ncbi.nlm.nih.gov/22190006

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Serum anti-Helicobacter pylori IgG antibodies and pepsinogens A and C as serological markers of chronic atrophic gastritis

1 reference

https://pubmed.ncbi.nlm.nih.gov/22190006

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Gastric precancerous process in a high risk population: cohort follow-up

1 reference

https://pubmed.ncbi.nlm.nih.gov/22190006

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Intestinal metaplasia of human stomach displays distinct patterns of mucin (MUC1, MUC2, MUC5AC, and MUC6) expression

1 reference

https://pubmed.ncbi.nlm.nih.gov/22190006

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Is type III intestinal metaplasia an obligatory precancerous lesion in intestinal-type gastric carcinoma?

1 reference

https://pubmed.ncbi.nlm.nih.gov/22190006

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Endoscopic screening for gastric cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/22190006

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Correlation of gross gastroscopic findings with gastroscopic biopsy in gastritis

1 reference

https://pubmed.ncbi.nlm.nih.gov/22190006

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Biopsy strategies for endoscopic surveillance of pre-malignant gastric lesions

1 reference

https://pubmed.ncbi.nlm.nih.gov/22190006

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Progression of chronic atrophic gastritis associated with Helicobacter pylori infection increases risk of gastric cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/22190006

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Surface pattern classification by enhanced-magnification endoscopy for identifying early gastric cancers

1 reference

https://pubmed.ncbi.nlm.nih.gov/22190006

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Evaluation of optimal gastric mucosal biopsy site and number for identification of Helicobacter pylori, gastric atrophy and intestinal metaplasia.

1 reference

https://pubmed.ncbi.nlm.nih.gov/22190006

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Stomach cancer history in the siblings of patients with gastric carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/22190006

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Relationship of Gastroscopic Features to Histological Findings in Gastritis andHelicobacter PyloriInfection in a General Population Sample

1 reference

https://pubmed.ncbi.nlm.nih.gov/22190006

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

[Glutathione S-transferases (GSTM1, GSTT1 and GSTP1) and N-acetyltransferase 2 polymorphisms and the risk of gastric cancer].

1 reference

https://pubmed.ncbi.nlm.nih.gov/22190006

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Human gastric carcinogenesis: a multistep and multifactorial process--First American Cancer Society Award Lecture on Cancer Epidemiology and Prevention

1 reference

https://pubmed.ncbi.nlm.nih.gov/22190006

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A follow-up study of atrophic gastritis and intestinal metaplasia after eradication of Helicobacter pylori

1 reference

https://pubmed.ncbi.nlm.nih.gov/22190006

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Meta-analysis of genetic polymorphisms and gastric cancer risk: variability in associations according to race

1 reference

https://pubmed.ncbi.nlm.nih.gov/22190006

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Serum pepsinogens in relation to precancerous gastric lesions in a population at high risk for gastric cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/22190006

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Chemoprevention of gastric dysplasia: randomized trial of antioxidant supplements and anti-helicobacter pylori therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/22190006

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical significance of gastric dysplasia: a multicenter follow-up study. Gastrointestinal Endoscopic Pathology Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/22190006

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of Helicobacter pylori eradication on subsequent development of cancer after endoscopic resection of early gastric cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/22190006

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Magnifying narrow-band imaging versus magnifying white-light imaging for the differential diagnosis of gastric small depressive lesions: a prospective study

1 reference

https://pubmed.ncbi.nlm.nih.gov/22190006

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Agreement of endoscopic findings and serum pepsinogen levels as an indicator of atrophic gastritis

1 reference

https://pubmed.ncbi.nlm.nih.gov/22190006

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Eradication of Helicobacter pylori infection improved gastric mucosal atrophy and prevented progression of intestinal metaplasia, especially in the elderly population: a long-term prospective cohort study

1 reference

https://pubmed.ncbi.nlm.nih.gov/22190006

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Correlation between the prevalence of gastritis and gastric cancer in Japan

1 reference

https://pubmed.ncbi.nlm.nih.gov/22190006

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Interobserver variation in the histopathological assessment of Helicobacter pylori gastritis

1 reference

https://pubmed.ncbi.nlm.nih.gov/22190006

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Premalignant and early malignant lesions in the gastrointestinal tract: definitions, terminology, and problems

1 reference

https://pubmed.ncbi.nlm.nih.gov/22190006

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Screening markers for chronic atrophic gastritis in Chiapas, Mexico.

1 reference

https://pubmed.ncbi.nlm.nih.gov/22190006

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Topographic patterns of intestinal metaplasia and gastric cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/22190006

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Where has the tumor gone? The characteristics of cases of negative pathologic diagnosis after endoscopic mucosal resection

1 reference

https://pubmed.ncbi.nlm.nih.gov/22190006

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

In through the out door: serology for atrophic gastritis

1 reference

https://pubmed.ncbi.nlm.nih.gov/22190006

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Eradication diminishes enhancing effects of Helicobacter pylori infection on glandular stomach carcinogenesis in Mongolian gerbils.

1 reference

https://pubmed.ncbi.nlm.nih.gov/22190006

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Changes in gastric mucosal patterns seen by magnifying NBI during H. pylori eradication

1 reference

https://pubmed.ncbi.nlm.nih.gov/22190006

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Schistosomes, liver flukes and Helicobacter pylori. IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. Lyon, 7-14 June 1994

1 reference

https://pubmed.ncbi.nlm.nih.gov/22190006

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Gastric epithelial dysplasia: a prospective multicenter follow-up study from the Interdisciplinary Group on Gastric Epithelial Dysplasia

1 reference

https://pubmed.ncbi.nlm.nih.gov/22190006

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A simulation to evaluate screening for Helicobacter pylori infection in the prevention of peptic ulcers and gastric cancers

1 reference

https://pubmed.ncbi.nlm.nih.gov/22190006

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The cost-effectiveness of screening for Helicobacter pylori to reduce mortality and morbidity from gastric cancer and peptic ulcer disease: a discrete-event simulation model

1 reference

https://pubmed.ncbi.nlm.nih.gov/22190006

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical significance of pepsinogen A isozymogens, serum pepsinogen A and C levels, and serum gastrin levels

1 reference

https://pubmed.ncbi.nlm.nih.gov/22190006

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Diagnostic yield of gastric biopsy specimens when screening for preneoplastic lesions

1 reference

https://pubmed.ncbi.nlm.nih.gov/22190006

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Helicobacter pylori IgA and IgG antibodies, serum pepsinogen I and the risk of gastric cancer: changes in the risk with extended follow-up period

1 reference

https://pubmed.ncbi.nlm.nih.gov/22190006

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Association of interleukin-1 gene polymorphisms with gastric cancer: a meta-analysis

1 reference

https://pubmed.ncbi.nlm.nih.gov/22190006

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Detection of gastric cancer by repeat endoscopy within a short time after negative examination

1 reference

https://pubmed.ncbi.nlm.nih.gov/22190006

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Serum pepsinogen I and II levels in various gastric disorders with special reference to their use as a screening test for carcinoma stomach

1 reference

https://pubmed.ncbi.nlm.nih.gov/22190006

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Epithelial dysplasia in atrophic gastritis. Bioptical follow-up study

1 reference

https://pubmed.ncbi.nlm.nih.gov/22190006

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Evaluation of blood tests to predict normal gastric mucosa

1 reference

https://pubmed.ncbi.nlm.nih.gov/22190006

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Magnifying endoscopy combined with narrow-band imaging for differential diagnosis of superficial depressed gastric lesions

1 reference

https://pubmed.ncbi.nlm.nih.gov/22190006

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Diagnostic accuracy of the serum profile of gastric mucosa in relation to histological and morphometric diagnosis of atrophy

1 reference

https://pubmed.ncbi.nlm.nih.gov/22190006

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Biopsy sites suitable for the diagnosis of Helicobacter pylori infection and the assessment of the extent of atrophic gastritis

1 reference

https://pubmed.ncbi.nlm.nih.gov/22190006

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Serum pepsinogen as a new marker for gastric carcinoma among young adults. Research Group on Prevention of Gastric Carcinoma among Young Adults

1 reference

https://pubmed.ncbi.nlm.nih.gov/22190006

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The clinical value of taking routine biopsies from the incisura angularis during gastroscopy

1 reference

https://pubmed.ncbi.nlm.nih.gov/22190006

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Is mild gastric epithelial dysplasia an indication for follow-up?

1 reference

https://pubmed.ncbi.nlm.nih.gov/22190006

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Correlation of ratio of serum pepsinogen I and II with prevalence of gastric cancer and adenoma in Japanese subjects.

1 reference

https://pubmed.ncbi.nlm.nih.gov/22190006

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Precancerous gastric lesions in a population at high risk of stomach cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/22190006

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical and economic effects of population-based Helicobacter pylori screening to prevent gastric cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/22190006

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S00428-011-1177-8

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22190006%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22190006%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q57698678&oldid=1934499108"